Israel Cap Invest Mkt Index MSCI Ishares (EIS) 48.
Post# of 273242
Posted On: 09/19/2016 3:07:23 PM
Israel Cap Invest Mkt Index MSCI Ishares (EIS) 48.75 $EIS
Israeli ETFs Head to Head: EIS vs. ITEQ
Zacks Equity Research - ZACKS - Mon Nov 30, 7:56AM CST
Given growth potential, it would be worthwhile to look at two ETFs focused on Israel and examine their key differences.
ITEQ: 25.26 (+0.19), EIS: 48.75 (+0.35), MSFT: 57.16 (-0.09), INTC: 37.32 (-0.35), GOOG: 768.52 (-0.36)
Israel ETFs Surge on Teva Megamerger Deal (revised)
Sweta Killa - ZACKS - Fri Jul 31, 3:11AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 152.81 (-0.53), AGN: 245.93 (+0.74), PPH: 58.60 (-0.10), EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), MYL: 41.50 (-0.29), TEVA: 50.73 (-1.01)
Israel ETFs Surge on Teva Megamerger Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jul 28, 9:50AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 152.81 (-0.53), AGN: 245.93 (+0.74), PPH: 58.60 (-0.10), EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), TEVA: 50.73 (-1.01)
iShares MSCI Israel Capped Index Fund Up 10.9% Since SmarTrend Uptrend Call (EIS)
Comtex SmarTrend(R) - Mon Apr 27, 9:32AM CDT
SmarTrend identified an Uptrend for iShares MSCI Israel Capped Index Fund (NYSE:EIS) on February 17th, 2015 at $47.75. In approximately 2 months, iShares MSCI Israel Capped Index Fund has returned 10.86% as of today's recent price of $52.93.
EIS: 48.75 (+0.35)
Teva/Mylan Deal Doesn’t Stir Pharma ETFs
ETFtrends.com - ETF Trends - Fri Apr 17, 2:00PM CDT
On a down day for U.S. stocks, even the latest rumor of a mega pharmaceuticals deal is proving ineffective in propping up exchange traded funds tracking the industry. Multiple media outlets are reporting that Israeli generic drug giant Teva...
EIS: 48.75 (+0.35), PJP: 63.36 (-0.02), ISRA: 28.11 (+0.24)
Pharma Focus Fabulous for Israel ETFs
ETFtrends.com - ETF Trends - Wed Apr 15, 11:00AM CDT
Increased mergers and acquisitions in the pharmaceuticals space has been a boon for healthcare-heavy Israel exchange traded funds. Year-to-date, the Market Vectors Israel ETF (NYSEArca: ISRA ) and the iShares MSCI Israel Capped ETF (NYSEArca: ...
EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24)
Inside The Surging Israel ETFs - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Apr 14, 10:10AM CDT
Israeli ETFs have been on the rise and are clearly crushing the global market.
PRGO: 93.36 (+0.06), ACWI: 58.14 (+0.31), SPY: 214.03 (+0.66), GAF: 59.13 (-0.24), GULF: 16.62 (-0.05), EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), TEVA: 50.73 (-1.01)
Healthcare Exposure Lifts Some International ETFs
ETFtrends.com - ETF Trends - Thu Apr 02, 6:30AM CDT
The Health Care Select Sector SPDR (NYSEArca: XLV ) was the best of the nine sector SPDR exchange traded funds in the first quarter, rising 6.3% while easily topping the 4.8% returned by the second best SPDR, the Consumer Discretionary Select...
EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), EDEN: 56.01 (+0.01)
Israel ETFs in Focus on Surprise Rate Cut - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Feb 26, 8:30AM CST
A surprise interest rate cut should benefit Israeli economy leading to surge in stock prices and ETFs but would weigh on the currency.
PRGO: 93.36 (+0.06), EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), TEVA: 50.73 (-1.01)
Central Bank Rate Cut, Loose Policies to Bolster Israel ETFs
ETFtrends.com - ETF Trends - Tue Feb 24, 9:30AM CST
The Israeli markets and related exchange traded funds could begin to strengthen after the Bank of Israel joined the growing group of central banks implementing loose monetary policies to foster growth. Year-to-date, the Market Vectors Israel ETF...
EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24)
Israeli ETFs Head to Head: EIS vs. ITEQ
Zacks Equity Research - ZACKS - Mon Nov 30, 7:56AM CST
Given growth potential, it would be worthwhile to look at two ETFs focused on Israel and examine their key differences.
ITEQ: 25.26 (+0.19), EIS: 48.75 (+0.35), MSFT: 57.16 (-0.09), INTC: 37.32 (-0.35), GOOG: 768.52 (-0.36)
Israel ETFs Surge on Teva Megamerger Deal (revised)
Sweta Killa - ZACKS - Fri Jul 31, 3:11AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 152.81 (-0.53), AGN: 245.93 (+0.74), PPH: 58.60 (-0.10), EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), MYL: 41.50 (-0.29), TEVA: 50.73 (-1.01)
Israel ETFs Surge on Teva Megamerger Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jul 28, 9:50AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 152.81 (-0.53), AGN: 245.93 (+0.74), PPH: 58.60 (-0.10), EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), TEVA: 50.73 (-1.01)
iShares MSCI Israel Capped Index Fund Up 10.9% Since SmarTrend Uptrend Call (EIS)
Comtex SmarTrend(R) - Mon Apr 27, 9:32AM CDT
SmarTrend identified an Uptrend for iShares MSCI Israel Capped Index Fund (NYSE:EIS) on February 17th, 2015 at $47.75. In approximately 2 months, iShares MSCI Israel Capped Index Fund has returned 10.86% as of today's recent price of $52.93.
EIS: 48.75 (+0.35)
Teva/Mylan Deal Doesn’t Stir Pharma ETFs
ETFtrends.com - ETF Trends - Fri Apr 17, 2:00PM CDT
On a down day for U.S. stocks, even the latest rumor of a mega pharmaceuticals deal is proving ineffective in propping up exchange traded funds tracking the industry. Multiple media outlets are reporting that Israeli generic drug giant Teva...
EIS: 48.75 (+0.35), PJP: 63.36 (-0.02), ISRA: 28.11 (+0.24)
Pharma Focus Fabulous for Israel ETFs
ETFtrends.com - ETF Trends - Wed Apr 15, 11:00AM CDT
Increased mergers and acquisitions in the pharmaceuticals space has been a boon for healthcare-heavy Israel exchange traded funds. Year-to-date, the Market Vectors Israel ETF (NYSEArca: ISRA ) and the iShares MSCI Israel Capped ETF (NYSEArca: ...
EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24)
Inside The Surging Israel ETFs - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Apr 14, 10:10AM CDT
Israeli ETFs have been on the rise and are clearly crushing the global market.
PRGO: 93.36 (+0.06), ACWI: 58.14 (+0.31), SPY: 214.03 (+0.66), GAF: 59.13 (-0.24), GULF: 16.62 (-0.05), EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), TEVA: 50.73 (-1.01)
Healthcare Exposure Lifts Some International ETFs
ETFtrends.com - ETF Trends - Thu Apr 02, 6:30AM CDT
The Health Care Select Sector SPDR (NYSEArca: XLV ) was the best of the nine sector SPDR exchange traded funds in the first quarter, rising 6.3% while easily topping the 4.8% returned by the second best SPDR, the Consumer Discretionary Select...
EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), EDEN: 56.01 (+0.01)
Israel ETFs in Focus on Surprise Rate Cut - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Feb 26, 8:30AM CST
A surprise interest rate cut should benefit Israeli economy leading to surge in stock prices and ETFs but would weigh on the currency.
PRGO: 93.36 (+0.06), EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24), TEVA: 50.73 (-1.01)
Central Bank Rate Cut, Loose Policies to Bolster Israel ETFs
ETFtrends.com - ETF Trends - Tue Feb 24, 9:30AM CST
The Israeli markets and related exchange traded funds could begin to strengthen after the Bank of Israel joined the growing group of central banks implementing loose monetary policies to foster growth. Year-to-date, the Market Vectors Israel ETF...
EIS: 48.75 (+0.35), ISRA: 28.11 (+0.24)
(0)
(0)Scroll down for more posts ▼